• FREE

    Rheumatoid Arthritis (RA): Optimizing Pharmacotherapeutic Management Strategies

    Some have suggested that criteria for the diagnosis of Rheumatoid Arthritis used for the past two decades are inadequate for addressing the disease burden of RA because by the time a physician detects rheumatoid nodules or radiographic erosion, the optimal time has passed for treatment initiation, representing a gap in care relating to diagnosis of disease.

    By the end of Rheumatoid Arthritis (RA): Optimizing Pharmacotherapeutic Management Strategies, you will be able to:
    • Describe the pathophysiology of RA such that it might inform treatment mechanisms.
    • Describe professional guideline recommendations’ approaches to the diagnosis and treatment of RA and, where applicable, apply them to patient cases
    • Identify the currently available and emerging pharmacotherapeutic treatments for management of RA and apply them to patient cases using evidence-based medicine.
    • Evaluate a treatment plan for a specific patient with RA to optimize safety and efficacy, suggesting modifications for improvement, including the management of comorbidities.
    • Describe the challenges and barriers to care associated with treating patients with RA.

    Target Audience:
    Rheumatologists and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in rheumatology; and any other health care providers with an interest in or who clinically encounter patients with RA.

    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: September 04, 2017
    • Expiration of CME credit: September 04, 2019
  • FREE

    ScientiaCME Immunology-Rheumatology CME

    ScientiaCME Immunology-Rheumatology CME has two selections offering CME:
    Rheumatoid Arthritis (RA): Therapeutic Updates and Optimizing Treatment (1 hr CME)
    Psoriatic Arthritis: Therapeutic Updates and Optimizing Treatment (1 hr CME)

    Target Audience: Physicians focusing on Allergy, Rheumatology.

    • Cost: Free
    • Credit hours: 2
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Expiration of CME credit: Two years after release
  • FREE

    Systemic Sclerosis Interstitial Lung Disease (SSc-ILD): Optimizing Treatment Strategies

    Systemic Sclerosis Interstitial Lung Disease (SSc-ILD): Optimizing Treatment Strategies is a free CME course that looks into the diangosis and treatment of Systemic Sclerosis Interstitial Lung Disease (SSc-ILD).

    Topics covered in this course include

    • SSc-ILD Epidemiology and risk factors
    • SSc-ILD Pathophysiology
    • SSc-ILD Diagnosis
    • Treatment of SSc-ILD
    • SSc-ILD

    After completing this course, you will better be able to:

    • Describe the etiology of SSc-ILD and its impact on patient clinical presentation and available pharmacotherapeutic treatments
    • Describe the prevalence, clinical features, and presentation of SSc-ILD
    • Evaluate treatments plans for SSc-ILD patients and suggest appropriate therapies, where applicable, based on individual presentations
    • Describe present and emerging drug therapies for management of SSc-ILD and apply them to patient cases taking into account the patient’s history
    • Describe clinical and logistical challenges associated with treating and educating patients with SSc-ILD

    Target audience: The following HCPs: pulmonologists, rheumatologists, primary care physicians, pathologists, dermatologists; physician assistants, nurse practitioners, nurses, and pharmacists specializing in pulmonology; and any other HCPs who have an interest in or otherwise clinically encounter patients with Ssc-ILD.

    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: August 20, 2018
    • Expiration of CME credit: July 20, 2020